Impaired vision usually results from damage incurred to the lens, retina, or cornea of your eye. This damage can be caused by factors such as old age, health conditions and excessive exposure to the sun. One health condition that can compromise your vision is diabetic retinopathy. Diabetic retinopathy develops due to diabetes. High blood sugar levels can cause damage to the blood vessels of the retina. If left untreated, this condition can even eventually lead to blindness.
You can stop diabetic retinopathy from developing by taking appropriate measures. After visiting your GP or optometrist and you’ve recognized the symptoms of diabetic retinopathy, you can take the right medication for it. A medication to consider is Retiplus, an eye care supplement for diabetic retinopathy.
There are hardly any symptoms of diabetic retinopathy in its early stages. That’s why it’s so important that you have your eyes screened regularly if you are diabetic. Symptoms you have to look out for are impairment, blurring of your vision, or eye pain. You should see a doctor without further delay if you experience any of these symptoms.
Retiplus Eye Care Supplement is the latest supplement for daily use that fights against the effects of diabetic retinopathy. Retiplus prevents deteriorating eyesight and replenishes the cells damaged by the condition with key nutrients in order to improve vision.
Retiplus Eye Care Supplement contains a mixture of key nutrients to help revitalize the damaged cells and maintain eye health. Retiplus contains Alpha Lipoic Acid and other essential vitamins to help prevent macular degeneration, which can occur due to diabetes. When taken daily, Retiplus can help improve vision.
Medical studies have indicated that taking oral antioxidant supplements like Retiplus Eye Supplements may improve the eye problem symptoms of those with type II diabetes, whether or not they have a background or pre-proliferative diabetic retinopathy. Research has shown a decline in the progression of the condition in those who had been taking the supplements compared to those who had not.
A study that took place over 5 years, studying antioxidant supplementation in the treatment of diabetic retinopathy was published in the European Journal of Ophthalmology in September 2011.
It was a report on a clinical trial that was rumored to be the first of its kind.
The study concentrated on type 2 diabetes patients who had non-proliferative diabetic retinopathy (DR). 105 patients participated in the study.
Each patient had a complete eye examination prior to taking part in the trial. Researchers acquired a plasma determination of oxidative (malonyldialdehyde [MDA]) and antioxidant parameters (total antioxidant status [TAS]) at the starting point.
A number of participants were randomly chosen and allocated oral antioxidant supplementation at the appropriate nutritional doses.
97 out of the 105 patients completed the 5-year follow-up period, and the same examinations (complete ophthalmic, MDA, and TAS) were done on those patients.
The following were compared at the beginning of the study and again at the end of follow-up:
- Visual acuity
- DR score
- MDA value
- TAS value
The study found that supplementation with an oral antioxidant did not significantly change visual acuity. However, the retinopathy stage did show a slowing of progression for those taking the supplement; but those who were not taking the supplement found no improvement in their retinopathy. In addition, those taking the supplement maintained antioxidant plasma status levels.
The study proved that oral antioxidant supplementation may be an effective therapy for patients with type 2 diabetes with non-proliferative diabetic retinopathy to improve their symptoms.